Yang S - Search Results

1

Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients.

Yang S, Liu Z, Liu S, Ding L, Chen K, Hua W, Zhang S. Yang S, et al. Clin Biochem. 2018 Sep;59:25-30. doi: 10.1016/j.clinbiochem.2018.06.006. Epub 2018 Jun 15. Clin Biochem. 2018. PMID: 29913121

2

[Association of serum free triiodothyronine with long-term outcome in heart failure patients receiving cardiac resynchronization therapy].

Mi J, Liu Z, Yang S, Hua W, Chen K, Ding L, Zhang S. Mi J, et al. Among authors: yang s. Zhonghua Yi Xue Za Zhi. 2015 Dec 19;95(48):3903-7. doi: 10.3760/cma.j.issn.0376-2491.2015.48.006. Zhonghua Yi Xue Za Zhi. 2015. PMID: 27122210 Chinese.

3

Significant mitral regurgitation as a predictor of long-term prognosis in patients receiving cardiac resynchronisation therapy.

Jin H, Yang S, Hua W, Gu M, Niu H, Ding L, Wang J, Xue C, Zhang S. Jin H, et al. Among authors: yang s. Kardiol Pol. 2018;76(6):987-992. doi: 10.5603/KP.a2018.0035. Epub 2018 Feb 5. Kardiol Pol. 2018. PMID: 29399763 Free article.

4

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score.

Yang S, Liu Z, Hu Y, Jing R, Gu M, Niu H, Ding L, Xing A, Zhang S, Hua W. Yang S, et al. BMC Cardiovasc Disord. 2020 Apr 28;20(1):205. doi: 10.1186/s12872-020-01460-x. BMC Cardiovasc Disord. 2020. PMID: 32345229 Free PMC article.

5

Validation of Three European Risk Scores to Predict Long-Term Outcomes for Patients Receiving Cardiac Resynchronization Therapy in an Asian Population.

Yang S, Liu Z, Li W, Hu Y, Liu S, Jing R, Hua W. Yang S, et al. J Cardiovasc Transl Res. 2021 Aug;14(4):754-760. doi: 10.1007/s12265-020-09999-y. Epub 2020 May 5. J Cardiovasc Transl Res. 2021. PMID: 32372168

6

A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy.

Cai M, Hua W, Zhang N, Yang S, Hu Y, Gu M, Niu H, Zhang S. Cai M, et al. Among authors: yang s. BMC Cardiovasc Disord. 2020 May 13;20(1):221. doi: 10.1186/s12872-020-01502-4. BMC Cardiovasc Disord. 2020. PMID: 32404049 Free PMC article.

7

A Predictive Model for Super-Response to Cardiac Resynchronization Therapy: The QQ-LAE Score.

Liu X, Hu Y, Hua W, Yang S, Gu M, Niu HX, Ding LG, Wang J, Zhang S. Liu X, et al. Among authors: yang s. Cardiol Res Pract. 2020 Aug 28;2020:3856294. doi: 10.1155/2020/3856294. eCollection 2020. Cardiol Res Pract. 2020. PMID: 32908692 Free PMC article.

8

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy.

Jing R, Jin H, Hua W, Yang S, Hu Y, Zhang S. Jing R, et al. Among authors: yang s. Korean Circ J. 2020 Dec;50(12):1062-1073. doi: 10.4070/kcj.2019.0420. Epub 2020 Oct 7. Korean Circ J. 2020. PMID: 33150752 Free PMC article.

9

Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response.

Yang S, Hu Y, Zhao J, Jing R, Wang J, Gu M, Niu H, Chen L, Hua W. Yang S, et al. ESC Heart Fail. 2021 Feb;8(1):280-290. doi: 10.1002/ehf2.13037. Epub 2020 Nov 19. ESC Heart Fail. 2021. PMID: 33211407 Free PMC article.

10

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy.

Zhao J, Yang S, Jing R, Jin H, Hu Y, Wang J, Gu M, Niu H, Zhang S, Chen L, Hua W. Zhao J, et al. Among authors: yang s. Front Cardiovasc Med. 2020 Nov 10;7:597546. doi: 10.3389/fcvm.2020.597546. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33240942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,600 results

Search Page

Filters